InvestorsHub Logo

jessellivermore

08/26/15 8:06 AM

#57424 RE: Ray #57422

Ray...

Very scary market action agree with your concerns. This is nothing personal, but a global effect.

":>) JL

Sam81

08/26/15 8:22 AM

#57427 RE: Ray #57422

Ray, ur welcome. A pleasure sharing the numbers with you guys since i have access to. I agree with you, scripts increase with the latest positive developments are the main catalyst in the short term.
The performance lately was mainly due to what is happening to the markets, but i have my doubts regarding the $1.58 level (printed on Monday) basically due to the fact that at such levels, we will have a market cap of around $292 million (with 185m shares outstanding) and assuming a total yearly sales in 2015 of around 75m-80m, a 5 to 6 times multiple will give us a fair valuation of around $450m, ie a price of $2.40 - $2.50 which is the level we were stuck at lately
(of course that is a basic assumption without taking into consideration debt and cash on hands, inventories...etc)

Again, as you stated, scripts are the main catalyst for the near future until we reach interim red-it in 2016

TortLaw

08/26/15 9:12 AM

#57431 RE: Ray #57422

What was the volume on that $1.58 print that you mention? Of note: there was also a 2 million share print @ 2 bucks yesterday. I would love to hear opinions of how, if at all, these two events affect each other in terms of "coloring the picture"? Thanks.

sts66

08/26/15 5:09 PM

#57510 RE: Ray #57422

Don't forget that large shorts don't work in isolation - if they are short AMRN, they are likely short on a bunch of biotechs - only need to be right 51% of the time to make money, and since a 90%+ number of new drugs fail to get to market, the odds are one their sides.